Rep. Mike Bost

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Maddy summaryThis bill prohibits federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they won't perform or fund abortions (with exceptions for rape/incest or life-threatening conditions). It redirects $235 million in existing funding to community health centers for women's health services like contraception, cancer screenings, and prenatal care. The bill explicitly states that redirected funds will continue to support all women's health services previously provided by Planned Parenthood. It also requires repayment of funds if Planned Parenthood violates the certification, and clarifies that overall federal funding for women's health services remains unchanged.

Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.

Maddy summaryThis bill requires healthcare providers to give the same medical care to infants born alive during abortions as they would to any newborn, and to immediately admit such infants to a hospital. It mandates reporting of non-compliance to law enforcement and imposes penalties including up to 5 years in prison for violations. Women who undergo abortions can file civil lawsuits seeking money damages for injuries, three times the abortion cost, and punitive damages if care standards are not met. The bill also clarifies that abortion includes intentionally killing an unborn child or terminating pregnancy without specific exceptions (e.g., after viability to preserve life or removing a dead fetus).

Maddy summaryHR 23, the Family and Small Business Taxpayer Protection Act, rescinds unobligated funds previously allocated to the Internal Revenue Service (IRS) under the Inflation Reduction Act of 2022. Specifically, it cancels unused balances from certain IRS funding provisions (sections 10301(1)(A)(ii), (iii), (B), (2), (3), (4), and (5)) of the Inflation Reduction Act. This bill does not change tax laws or directly affect taxpayers; it only redirects unspent IRS budget authority. The provision applies solely to funds that were not obligated by the IRS as of the bill’s enactment date.

Maddy summaryHR 461, the "Protecting Individuals with Down Syndrome Act," prohibits abortions performed specifically because an unborn child has been diagnosed with Down syndrome. The bill amends Title 18 to make it a federal offense for medical providers to perform or facilitate such abortions, with criminal penalties of up to 5 years in prison or fines. It also establishes civil remedies allowing women, fathers, or maternal grandparents to sue providers for damages, including punitive damages, while protecting women from prosecution for seeking these abortions. The law requires medical professionals to report suspected violations and includes strict privacy protections for women in court proceedings. This bill directly affects abortion providers and medical professionals who perform or facilitate abortions based on Down syndrome diagnosis, without altering broader abortion laws.

Maddy summaryHR 484, the Natural Gas Tax Repeal Act, repeals Section 136 of the Clean Air Act, which established a methane emissions and waste reduction incentive program for natural gas systems. This directly affects natural gas operators who previously participated in the program by ending their eligibility for associated incentives. The bill also rescinds any unobligated funds allocated under that program before its repeal. The change removes a federal requirement for the industry to reduce methane emissions through this specific incentive mechanism.

Maddy summaryHR 175, the Heartbeat Protection Act of 2023, prohibits physicians from performing abortions without first checking for a detectable fetal heartbeat using standard medical practice and informing the patient of the results. It allows exceptions only for abortions necessary to save a mother’s life due to physical conditions (not psychological ones), or for pregnancies resulting from rape or incest against an adult or minor, which require specific documentation like counseling records or police reports. Physicians violating the law face up to five years in prison, while patients cannot be prosecuted. The bill defines "unborn child" as beginning at fertilization and mandates detailed medical documentation for all exceptions. It explicitly excludes psychological conditions from life-threatening exceptions and requires physicians to retain records per federal health privacy rules.

Maddy summaryHCONRES 3 is a non-binding congressional resolution expressing support for pro-life facilities, groups, and churches targeted by vandalism and threats following the Supreme Court's Dobbs decision. It condemns specific incidents like graffiti, window-smashing, and arson at pregnancy centers and churches (e.g., in Frederick, MD, and Portland, OR), while recognizing the role of these organizations in supporting pregnant women. The resolution calls on the Biden Administration to use law enforcement to protect these facilities but does not create new laws or policies. As a symbolic measure, it has no legal effect on the incidents described.

Maddy summaryThis bill blocks federal funding for colleges that operate or partner with campus health clinics providing abortion drugs or abortions to students or staff. It requires institutions receiving federal funds to annually certify that no such services are offered at their on-campus clinics. The law specifically excludes hospital-based clinics from coverage and defines "abortion drugs" as medications intended to terminate pregnancy (excluding specific medical exceptions). It directly affects public and private colleges receiving federal aid, as most institutions of higher education qualify for such funding.